Difference of carboplatin clearance estimated by the Cockroft–Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula

Lokich, 1998, Carboplatin versus cisplatin in solid tumors: an analysis of the literature, Ann. Oncol., 9, 13, 10.1023/A:1008215213739 Dupont, 2004, Chemotherapeutic agents used in the treatment of gynecologic malignancies, 17 McGuire, 1996, Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer, N. Engl. J. Med., 334, 1, 10.1056/NEJM199601043340101 McGuire, 1999, The Gynecologic Oncology Group experience in ovarian cancer, Ann. Oncol., 10, 29, 10.1023/A:1008303300675 Piccart, 2000, Randomized intergroup trial of cisplatin–paclitaxel versus cisplatin–cyclophosphamide in women with advanced epithelial ovarian cancer: three year results, J. Natl. Cancer Inst., 92, 699, 10.1093/jnci/92.9.699 Neijt, 2000, Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian carcinoma, J. Clin. Oncol., 18, 3084, 10.1200/JCO.2000.18.17.3084 du Bois, 1999, Cisplatin/paclitaxel vs. carboplatin/paclitaxel in ovarian cancer: update of an Arbeitsgemeinshaft Gynaekologishe Onkologie (AGO) Study Group Trial, Proc. Am. Soc. Clin. Oncol., 18, 356a Ozols, 1999, Randomized phase III study of cisplatin (CIS)/paclitaxel (PAC) versus carboplatin (CARBO)/PAC in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncology Group Trial (GOG 158), Proc. Am. Soc. Clin. Oncol., 18, 356a Duffull, 1997, Clinical pharmacokinetics and dose optimization of carboplatin, Clin. Pharmacokinet., 33, 161, 10.2165/00003088-199733030-00002 Jodrell, 1992, Relationship between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer, J. Clin. Oncol., 10, 520, 10.1200/JCO.1992.10.4.520 Sorensen, 1991, Dose–toxicity relationship of carboplatin in combination with cyclophosphamide in ovarian cancer patients, Cancer Chemother. Pharmacol., 28, 397, 10.1007/BF00685696 Calvert, 1989, Carboplatin dosage: prospective evaluation of a simple formula based on renal function, J. Clin. Oncol., 7, 1150, 10.1200/JCO.1989.7.11.1748 Martino, 1999, Efficacy of 51Cr-EDTA clearance to tailor a carboplatin therapeutic regimen in ovarian cancer patients, Anticancer Res., 19, 5587 Cockroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Wright, 2001, Estimation of glomerular filtration rate in cancer patients, Br. J. Cancer, 84, 452, 10.1054/bjoc.2000.1643 Jelliffe, 1973, Creatinine clearance: bedside estimate, Ann. Intern. Med., 79, 604, 10.7326/0003-4819-79-4-604 Chatelut, 1995, Prediction of carboplatin clearance from standard morphological and biological patient characteristics, J. Natl. Cancer Inst., 87, 573, 10.1093/jnci/87.8.573 Jodrell, 1999, Formula-based dosing for carboplatin, Eur. J. Cancer, 35, 1299, 10.1016/S0959-8049(99)00127-6 Calvert, 1997, A review of the pharmacokinetics and pharmacodynamics of combination carboplatin/paclitaxel, Semin. Oncol., 24, 85 Millward, 1996, Carboplatin dosing based on measurement of renal function—experience at the Peter MacCallum Cancer Institute, Aust. N. Z. J. Med., 26, 372, 10.1111/j.1445-5994.1996.tb01925.x Huitema, 2000, Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods, Clin. Pharmacol. Ther., 67, 621, 10.1067/mcp.2000.106827 Marx, 2004, Evaluation of the Cockroft–Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients, Ann. Oncol., 15, 291, 10.1093/annonc/mdh079 Poole, 2002, A comparison of bedside renal function estimates and measured glomerular filtration rate ([99mTc]-DTPA clearance) in cancer patients, Ann. Oncol., 13, 949, 10.1093/annonc/mdf236 Wright, 2001, Estimation of glomerular filtration rate in cancer patients, Br. J. Cancer, 84, 452, 10.1054/bjoc.2000.1643 Kasiske, 2000, Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy, 1129 Hsu, 2002, Methodological issues in studying the epidemiology of mild to moderate chronic renal sufficiency, Kidney Int., 61, 1567, 10.1046/j.1523-1755.2002.00299.x Nyengaard, 1992, Glomerular number and size in relation to age, kidney weight, and body surface in normal man, Anat. Rec., 232, 590, 10.1002/ar.1092320205 Donahue, 2001, Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing, Cancer Chemother. Pharmacol., 47, 373, 10.1007/s002800000260